NDC 62559-870

Bretylium Tosylate

Bretylium Tosylate

Bretylium Tosylate is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Bretylium Tosylate.

• Product ID: 62559-870_04048ad4-2e59-4456-9db0-1beac8f775aa
• NDC: 62559-870
• Product Type: Human Prescription Drug
• Proprietary Name: Bretylium Tosylate
• Generic Name: Bretylium Tosylate
• Dosage Form: Injection
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS
• Marketing Start Date: 2019-12-11
• Marketing Category: ANDA / ANDA
• Application Number: ANDA204386
• Labeler Name: ANI Pharmaceuticals, Inc.
• Substance Name: BRETYLIUM TOSYLATE
• Active Ingredient Strength: 50 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 62559-870-11

10 mL in 1 VIAL, SINGLE-DOSE (62559-870-11)

• Marketing Start Date: 2019-12-11
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62559-870-11 [62559087011]

Bretylium Tosylate INJECTION

• Marketing Category: ANDA
• Application Number: ANDA204386
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2019-12-11

Drug Details

Active Ingredients

Ingredient	Strength
BRETYLIUM TOSYLATE	50 mg/mL

NDC Crossover Matching brand name "Bretylium Tosylate" or generic name "Bretylium Tosylate"

NDC	Brand Name	Generic Name
61916-135	Bretylium Tosylate	Bretylium Tosylate
62559-870	Bretylium Tosylate	bretylium tosylate